Where is novo nordisk located

The facility uses recombinant DNA technology to produce insulin. The insulin production process begins with product formulation wherein human insulin crystals are mixed with chemical stabilisers and highly purified water. The resultant product is filled into glass vials and cartridges under aseptic conditions.

Following inspection, the products are packaged for distribution. The expansion will be funded through incentives. The Clayton site was chosen for expansion due to the amount of financial support through local and state resources. In October , Germany-based contract development and manufacturing organisation CDMO Aenova Group expanded its manufacturing capabilities at its site in…. The company began…. Get important industry news and analysis sent to your inbox — sign up to our e-Newsletter here.

News Analysis Analysis Comment Projects. We will collaborate proactively with suppliers to reduce the environmental impact across our supply chain, cut CO 2 emissions from all our operations and transportation, and solve the end-of-life product waste challenge to eliminate waste.

Follow our journey to achieve zero impact. We are a proud life science company united by a common job to discover better treatments for people living with a serious chronic disease. Our industry is dynamic.

And the scientific understanding of the diseases we treat and the people living with them, improves every day. This is a constant reminder that what got us to where we are today is not necessarily what will make us successful in the future. As an employer, we recognise the need to embrace experimentation and strive for diversity and inclusion to help make better decisions by ensuring that multiple perspectives are considered.

We work in close collaboration with leading universities and biotech companies worldwide to collaborate and speed up new drug discovery. We continuously seek new partners with whom we share complementary capabilities and mutual interests, and openly share novel peptide and protein analogues, and antibodies for preclinical research. We offer easy and free access to selected high-quality and well-characterised compounds to curious and passionate scientists from around the world.

See how to partner with us. Our story starts in when two small Danish companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists. When at last they decided to merge in , they created Novo Nordisk, a company that has been expanding rapidly ever since with leading positions within diabetes care, obesity care, haemophilia care, and growth hormone therapy. The Novo Nordisk Way is a set of guiding principles which underpins every decision we make.

To mark World Diabetes Day, we are celbrating a century of innovation in diabetes care. Explore the history. Our global partnership is now providing free care to 30, children and adolescents living with type 1 diabetes in low- and middle-income countries.

See our aspiration for Latest news. Read more.